Dementia 3. Vascular dementia: diagnosis, treatment and medical management
Linda Nazarko
Abstract
Linda Nazarko
Abstract
In the UK, an estimated 954 000 people have dementia. Vascular dementia (VaD) is the second most common type of dementia and affects around 257 607 people ( Prince et al, 2014:16 —Table 4). This article, the third in a series, explains about the pathophysiology and clinical features of VaD, how it can be prevented, how it is diagnosed and the medication used to treat VaD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In the UK, an estimated 954 000 people have dementia. Vascular dementia (VaD) is the second most common type of dementia and affects around 257 607 people ( Prince et al, 2014:16 —Table 4). This article, the third in a series, explains about the pathophysiology and clinical features of VaD, how it can be prevented, how it is diagnosed and the medication used to treat VaD.
Key concepts: Dementia, Vascular dementia, Medicine, Intensive care medicine, Psychiatry, Disease, Internal medicine